Charlie Qi

Chief Tech/Sci/R&D Officer at TRANSCENTA HOLDING LIMITED

Health Technology

Profile

Charlie Qi is currently the Senior Vice President-Global Clinical Development at Transcenta Holding Ltd.
and the Head-Oncology Product Development at Roche Global Product Development Center.
Previously, he worked as the Head-Medical Sciences at Hutchison MediPharma Ltd.
from 2012 to 2017.

Charlie Qi active positions

Companies	Position	Start
TRANSCENTA HOLDING LIMITED	Chief Tech/Sci/R&D Officer	2020-07-31
Roche Global Product Development Center	Corporate Officer/Principal	2017-07-31

All active positions of Charlie Qi

Former positions of Charlie Qi

Companies	Position	End
Hutchison MediPharma Ltd. Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.	Corporate Officer/Principal	2017-07-31

See the detail of Charlie Qi's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charlie Qi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
TRANSCENTA HOLDING LIMITED	Health Technology

Private companies	2
Hutchison MediPharma Ltd. Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.	Health Technology
Roche Global Product Development Center

See company connections